Management strategies of academic pigmented lesion clinic directors in the United States

Affiliations

¹ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
² Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah.
³ Department of Dermatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
⁴ Department of Dermatology, Emory University, Atlanta, Georgia; Division of Dermatology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia.
⁵ University of Arizona Cancer Center, Tucson, Arizona.
⁶ Scully-Welsh Cancer Center, Indian River Medical Center, Vero Beach, Florida.
⁷ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
⁸ Department of Dermatology, Oregon Health Sciences University, Portland, Oregon.
⁹ Dermatology Service, Memorial Sloan Kettering Skin Cancer Center, Hauppage, New York.
¹⁰ Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center, Stanford, California; Cancer Institute, Stanford, California; Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
¹¹ Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax, Virginia.
¹² Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: michael.ming@uphs.upenn.edu.

Kelly C Nelson et al. J Am Acad Dermatol. 2018 Aug.

. 2018 Aug;79(2):367-369.

doi: 10.1016/j.jaad.2017.12.069. Epub 2018 Jan 4.

¹ Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
² Department of Dermatology, University of Utah Health Sciences Center, Salt Lake City, Utah.
³ Department of Dermatology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
⁴ Department of Dermatology, Emory University, Atlanta, Georgia; Division of Dermatology, Atlanta Veterans Affairs Medical Center, Decatur, Georgia.
⁵ University of Arizona Cancer Center, Tucson, Arizona.
⁶ Scully-Welsh Cancer Center, Indian River Medical Center, Vero Beach, Florida.
⁷ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
⁸ Department of Dermatology, Oregon Health Sciences University, Portland, Oregon.
⁹ Dermatology Service, Memorial Sloan Kettering Skin Cancer Center, Hauppage, New York.
¹⁰ Department of Dermatology, Pigmented Lesion and Melanoma Program, Stanford University Medical Center, Stanford, California; Cancer Institute, Stanford, California; Dermatology Service, Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
¹¹ Inova Schar Cancer Institute, Department of Medicine, Virginia Commonwealth University, Fairfax, Virginia.
¹² Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: michael.ming@uphs.upenn.edu.

No abstract available

MeSH terms